Literature DB >> 6841558

Androgen binding capacity and 5 alpha-reductase activity in pubic skin fibroblasts from hirsute patients.

I Mowszowicz, E Melanitou, A Doukani, F Wright, F Kuttenn, P Mauvais-Jarvis.   

Abstract

We have measured the total (cytosolic plus nuclear) androgen binding capacity of pubic skin fibroblasts from nine patients with hirsutism of various origin. Confluent intact cell monolayers were incubated with increasing concentrations (0.05-2 nM) of [3H]dihydrotestosterone ([3H]DHT) with or without a 200-fold excess of unlabeled DHT. The androgen binding capacities (mean +/- SD) were similar in normal men (411 +/- 171 fmol/mg DNA), women (310 +/- 103 fmol/mg DNA), and hirsute patients (313 +/- 141 fmol/mg DNA) regardless of the plasma androgen levels. In contrast, the 5 alpha-reductase level in pubic skin fibroblasts (mean +/- SD) was, as previously described, higher in hirsute women (3.3 +/- 2.6 fmol/micrograms DNA . h) than in normal women (1.1 +/- 0.6 fmol/microgram DNA . h; P less than 0.05). We conclude from these data that: 1) increased androgen binding capacity cannot be held responsible for hypersensitivity to androgens in hirsutism; 2) the androgen receptor is not regulated by androgens in human skin, as similar levels are observed in men, women, and hirsute patients; 3) this contrasts with 5 alpha-reductase activity and emphasizes the importance of this enzyme as an amplifier of androgen action in areas where it is stimulated by androgens, such as pubic skin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841558     DOI: 10.1210/jcem-56-6-1209

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Finasteride. Does it affect spermatogenesis and pregnancy?

Authors:  M Pole; G Koren
Journal:  Can Fam Physician       Date:  2001-12       Impact factor: 3.275

3.  Paraadrenal Castleman disease presenting with adrenal hyperandrogenism.

Authors:  K Müssig; B Gallwitz; F Machicao; M Horger; H-U Häring; E Kaiserling
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.